logo
Frozen Chicken Products Recalled Across Canada—Here's What to Know

Frozen Chicken Products Recalled Across Canada—Here's What to Know

Yahoo20-02-2025
There's an active recall on frozen chicken nuggets sold across Canada, according to the Canadian Food Inspection Agency. This is due to bone fragments found in the product.
The Swiss Chalet brand chicken breast nuggets were sold in 700-gram boxes with a printed UPC of '066701011479' and best-by dates of September 7, 2025, or September 26, 2025. The nuggets are in the shapes of moons, stars and planets. This recall follows multiple customer complaints of injury after consuming the product due to pieces of bone in the nuggets.
Check your freezer, and if you have these nuggets on hand, dispose of them or return them to your place of purchase for a refund. Contact your doctor if you have experienced any injury or illness after eating this recalled chicken product.
For more information on this recall, contact the CFIA toll-free at 1-800-442-2342 or email information@inspection.gc.ca.
Related: Trader Joe's Just Recalled a Popular Frozen Item Due to Contamination—Here's What to Know
Read the original article on EATINGWELL
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Santhera extends Highbridge convertible bond to 30th September 2025
Santhera extends Highbridge convertible bond to 30th September 2025

Business Upturn

time3 days ago

  • Business Upturn

Santhera extends Highbridge convertible bond to 30th September 2025

By GlobeNewswire Published on August 15, 2025, 10:00 IST Ad hoc announcement pursuant to Art. 53 LRA Pratteln, Switzerland, 15 August, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces that by mutual agreement the Company and Highbridge Capital Management, LLC (Highbridge) have decided to extend the maturity date of the existing CHF 7 million private convertible bond, that has a strike price of CHF 10.00, to 30th September 2025. About Santhera Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular diseases with high unmet medical need. The Company has an exclusive license from ReveraGen for all indications worldwide to AGAMREE® (vamorolone), a dissociative steroid with novel mode of action, which was investigated in a pivotal study in patients with Duchenne muscular dystrophy (DMD) as an alternative to standard corticosteroids. AGAMREE for the treatment of DMD is approved in the U.S. by the Food and Drug Administration (FDA), in the EU by the European Medicines Agency (EMA), in the UK by the Medicines and Healthcare products Regulatory Agency (MHRA), in China by the National Medical Products Administration (NMPA) and Hong Kong by the Department of Health (DoH). Santhera has out-licensed rights to AGAMREE for North America to Catalyst Pharmaceuticals and for China and certain countries in Southeast Asia to Sperogenix Therapeutics. For further information, please visit AGAMREE® is a trademark of Santhera Pharmaceuticals. For further information please contact: Santhera Catherine Isted, Chief Financial Officer: [email protected] ICR Healthcare [email protected] Disclaimer / Forward-looking statements This communication does not constitute an offer or invitation to subscribe for or purchase any securities of Santhera Pharmaceuticals Holding AG. This publication may contain certain forward-looking statements concerning the Company and its business. Such statements involve certain risks, uncertainties and other factors which could cause the actual results, financial condition, performance or achievements of the Company to be materially different from those expressed or implied by such statements. Readers should therefore not place undue reliance on these statements, particularly not in connection with any contract or investment decision. The Company disclaims any obligation to update these forward-looking statements. # # # Attachment 250815 Highbridge Convertible Bond_ENGLISH_FINAL Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.

4 Best Hoof Trimmers For Safe and Easy Animal Grooming
4 Best Hoof Trimmers For Safe and Easy Animal Grooming

Time Business News

time7 days ago

  • Time Business News

4 Best Hoof Trimmers For Safe and Easy Animal Grooming

According to CowCare, clean and balanced hoofs minimize burden on joints and ligaments, supporting better physical health and mobility. This fact highlights how important it is to perform hoof cleaning within a certain period. Whether you're a farrier, veterinarian or livestock owner, a hoof trimmer is your indispensable ally when you aim to improve a pet's mobility and its posture. Hoof trimming is a tedious and time-consuming procedure, but it doesn't need to be in 2025. Thanks to the advanced tools that have entered the market this year, which reduce the effort involved, time consumed, but help to complete the job with better accuracy. This guide walks you through the best hoof trimmers so that you can make a smart choice aligned with your job. Hoof trimmers ensure pet hygiene, help it assume a proper posture and support proper weight distribution. When used professionally, these tools prevent lameness and other mobility problems, allowing the animals to stay physically fit and infection-free. Hoof trimmers are useful for different professionals and offer unique benefits to each segment: 1- For Farriers: cuts down the effort involved to perform the job and reduces hand fatigue. 2- For veterinarians: empowers them to make accurate cuts. 3- For Owners and Farmers: Quality Hoof trimmer means animals will have fewer issues like lameness and thus less frequent replacements. Features a length of 17', a protective green coating on the handle and blades that can open up to 1 1/4'. Ideal for equine hooves and comes with easy maintenance. Equipped with sharp blades, hoof trimming with the (DRTHCI8) model is efficient and easy. As its name suggests, it is suitable to cut and shape tough, large hooves on cattle and horses. Features an extended length of 30' that includes 25' hardwood handles and a 5' drop forged cutting head for better cutting. With its extra-sharp blades, it can easily cut large hooves with precision. Hoof Nippers serve the purpose of refining the shape of the trimmed hoof. Made from chrome Vanadium, it allows for precise cutting of the hoof wall, giving it a symmetric shape that improves the overall animal's look. Comes in different lengths to suit different types of animals or pets. Hoof knives are effective in maintaining proper hygiene of the hoof area by eliminating the abscesses, frog tissue and debris. It is a Swiss-made narrow blade that reduces tissue damage during precise veterinary procedures aimed at curing pets. 1- Blade Quality: Trimmers made from high-carbon steel last longer. 2- Handle Ergonomics: Prefer soft rubber grips and balanced weight for reduced hand fatigue and better operation. 3- Cutting action: Ensure the trimmer can perform compound cuts for better precision. 4-Animal Type: Trimmers with long handles are suitable for large livestock such as cows, horses, while compact trimmers work well for small pets like goats, sheep and alpacas. hoof trimmers excel in every department, whether it is cutting precision, durability or ergonomic behaviour. No matter if you are a farrier, veterinarian, or livestock owner, the importance of choosing the right hoof trimmer can't be underestimated. If you're in search of efficient but affordable Hoof trimmers in the USA, can be the ultimate destination. You will find a wide range of hoof trimming tools based on the use case, material and price. TIME BUSINESS NEWS

Novartis Gets Boost as Autoimmune Drug Suceeds in Key Trials
Novartis Gets Boost as Autoimmune Drug Suceeds in Key Trials

Bloomberg

time7 days ago

  • Bloomberg

Novartis Gets Boost as Autoimmune Drug Suceeds in Key Trials

Novartis AG succeeded in treating a form of autoimmune disease in late-stage studies, offering a boost for the Swiss drugmaker's potential for treatments in the field. Ianalumab showed improvement in disease activity in patients with Sjögren's disease, according to a statement Monday. The drug candidate was well tolerated and demonstrated a favorable safety profile for the disease, which has very limited treatment options.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store